Preventive Effect of Novel Bacterial Polysaccharide and Animal Splenic Protein as Natural Adjuvants on Animal Model of Asthma
- سال انتشار: 1391
- محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 15، شماره: 5
- کد COI اختصاصی: JR_IJBMS-15-5_010
- زبان مقاله: انگلیسی
- تعداد مشاهده: 315
نویسندگان
Department of Internal Medicine, Medical School of Islamic Azad University- Mashhad Branch, Mashhad, Iran
Mohaghagh Hazreati Immunology and Biotechnology Researches Centre, Tehran Iran
Department of Immunology, Medical School of Islamic Azad University, Mashhad Branch, Mashhad, Iran
Department of Pathology Razavi Hospital, Mashhad, Iran
Mashhad University of Medical Science, Mashhad, Iran
چکیده
Objective(s) Two new adjuvants from natural animal lipids (G۲) and bacterial polysaccharide extracts (PC) were previously prepared by our group and showed a reduction in tracheal responsiveness. The aim of this study was to evaluate the preventive effect of recently introduced natural products (G۲ and PC) on the development of asthma. Materials and Methods Asthma was induced using a standard method in four groups of BALB/c mice. A non-sensitized control group was also included in order to be compared with treated groups. Three groups were premedicated with novel agents named G۲, PC, and a combination of these two for ۲۰ days before starting the induction of asthma. Bronchoalveolar lavage fluid (BALF) was collected and analyzed for inflammatory cells. Interferon-γ, and IL-۴ and the histopathological of both lungs were also evaluated. Results In all pretreated groups, the inflammatory cells infiltration especially eosinophils and smooth muscle hyperplasia decreased significantly. BALF cytology also showed significant decrease in eosinophil count in all pretreated groups. There was a significant increase in the BALF and serum INF-γ in all pretreated groups but the combination of G۲/PC was more effective. BALF IL-۴ decreased significantly in the group pretreated with a combination of G۲ and G۲/PC (۴.۱۱±۰.۸۶ and ۴.۰۲±۰.۵۲ pg/ml in G۲ and G۲/PC, respectively). Serum IL-۴ in the PC group was significantly higher than the sensitized control. Conclusion G۲ and PC may effectively prevent asthma development by activation of the type ۱ T helper system.کلیدواژه ها
Asthma, Interleukin-۴, Immunomodulation, Interferon-gamma, prevention and control, Adjuvants, Immunologicاطلاعات بیشتر در مورد COI
COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.
کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.